News

Gemseki chosen as Top 10 by magazine

Gemseki, a member of SNBL Group, was chosen as one of the top 10 drug discovery service companies in APAC by Pharma Tech Outlook, and is the cover story of the September 2019 issue.

 

Meet SNBL at Eurotox 2019

 

 

 

 

SNBL will be exhibiting at the 55th Eurotox Congress from 8 - 11 September in Helsinki, Finland.

 

Drop by Booth #61 or email info@snbl.co.jp to see how SNBL can provide preclinical support for your drug development program.

 

 

 

 

 

 

0 Comments

Come visit us at the International Congress of Toxicology

 

 

 

 

Join SNBL from July 15 to 18 in Honolulu for the 15th International Congress of Toxicology. Drop by Booth 401 or email info@snbl.co.jp to see how SNBL can provide preclinical support for your drug development program.

 

 

 

 

 

 

Come visit us at the Teratology Society Meeting 2019

 

 

 

SNBL is known for its high quality developmental and reproductive preclinical studies, and we would be happy to discuss how we can help your drug development program at the annual Teratology Society Meeting in San Diego this June. Email info@snbl.co.jp to make an appointment or visit Booth #4.

 

 

 

 

 

Come visit us at BIO 2019

 

 

 

 

Are you attending BIO 2019 in Philadelphia June 3-6? SNBL will be at the JETRO booth #1509, and we would be happy to discuss how our preclinical safety testing can support your drug development program. Email info@snbl.co.jp to make an appointment.

 

 

 

 

 

Come visit us at ARVO 2019

 

 

 

 SNBL will be exhibiting at ARVO, The Association for Research in Vision and Ophthalmology, to be held in Vancouver from April 28 to May 2. We will be at Booth #1643 to introduce our new capability of OCT angiography for preclinical evaluation. Email us at info@snbl.co.jp to set up a meeting.

 

 

 

 

 

Honorable Mention at the 35th Scientific Meeting of JSTP

One of our pathologists at SNBL, Haruno Yabuki, DVM, received the top honorable mention for a poster she presented at the 35th Scientific Meeting of the Japanese Society of Toxicologic Pathology (JSTP). This meeting is a gathering of nearly all toxicologic pathologists in Japan, whether from pharmaceutical companies or CROs, educational institutions, or public research institutions, and was a great opportunity to show SNBL’s high level of scientific quality.

 

 

Congratulations Dr. Yabuki!

 

 

Health & Productivity Award 2019

For the third year in a row, SNBL Japan received the Health & Productivity Award, presented by the Japanese Ministry of Economy, Trade and Industry. This award recognizes organizations which promote health in their region by implementing strategies to improve the health and productivity of their employees.

 

As part of its strategy to improve employee health, SNBL Japan has implemented Wellness Tourism seminars, a series of health challenges, and early cancer screenings. SNBL Japan will strive to continue these efforts and ensure that the recognition of our strategy is meaningful.

 

 

Update of publications section

We have updated our publications section. We look forward to seeing the research that will be presented in 2019.

 

 

SNBL will give a preclinical seminar in Taiwan

We will host a joint seminar with Taiwan Research-Based Biopharmaceutical Manufacturers Association (TRPMA) in Taipei on January 23, 2019.

 

Up to now, drug development in Taiwan has largely operated based on manufacturing contracts; however, successful new drug development has seen an increase in active support from Taiwanese government policy.

 

SNBL will give lectures to Taiwanese pharmaceutical and biotech companies with the aim of shedding light on the current situation in Japan including topics such as the conduct of GLP studies and GLP monitoring authority in Japan, preclinical studies on biologics and advanced therapy products, and application of imaging techniques to pharmacology and toxicity studies.

 

This seminar will work to enhance mutual understanding and exchange ideas between Japan and Taiwan in order to facilitate drug development activities in both countries.

 

 

Update of posters section

We have updated our posters section. We look forward to seeing the research that will be presented in the new year.

 

 

2018 Prime Minister's Award

SNBL has received the 2018 Prime Minister's Award for leading businesses in the promotion of women from the Gender Equality Bureau Cabinet Office. This award recognizes companies that make a proactive effort in supporting women in managerial and executive positions. SNBL is the first company in Kagoshima to receive this award. SNBL knows that the viewpoints of women are essential not only to a successful business, but also to a prosperous society. We are honored to receive this award and hope that our practices can be a model for the rest of Kagoshima.